A. Walan
AstraZeneca (United Kingdom)(GB)AstraZeneca (Sweden)(SE)
Publications by Year
Research Areas
Helicobacter pylori-related gastroenterology studies, Gastroesophageal reflux and treatments, Eosinophilic Esophagitis, Antibiotics Pharmacokinetics and Efficacy, Pharmaceutical studies and practices
Most-Cited Works
- → Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosa(2000)544 cited
- → Effect of Omeprazole and Ranitidine on Ulcer Healing and Relapse Rates in Patients with Benign Gastric Ulcer(1989)382 cited
- → Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial(2003)220 cited
- → Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis(2007)171 cited
- → MAINTENANCE TREATMENT OF RECURRENT PEPTIC ULCER BY CIMETIDINE(1978)170 cited
- → CIMETIDINE IN THE TREATMENT OF ACTIVE DUODENAL AND PREPYLORIC ULCERS(1976)163 cited